Loading doctor profile...
Myeloma Specialist & Cellular Therapist, specializing in multiple myeloma
Dr. Sham Mailankody, MBBS, is a medical oncologist specializing in the care of patients with multiple myeloma and related plasma cell disorders at Memorial Sloan Kettering Cancer Center (MSK). He serves as Clinical Director of the Cellular Therapy Service and Research Director of the Myeloma Service at MSK, where he works alongside colleagues to identify optimal treatment strategies for patients with these complex conditions.
Dr. Mailankody's research is centered on the development of novel immune and cellular therapies for myeloma, with a particular focus on chimeric antigen receptor (CAR) T cell therapies. Through his dual leadership roles in cellular therapy and myeloma research, he is at the forefront of translating innovative treatment approaches into clinical practice for patients facing these challenging diagnoses.
His combined clinical and research responsibilities reflect a commitment to advancing the field of myeloma care through scientific discovery and hands-on patient management. By leading efforts in both cellular therapy and myeloma research at one of the world's premier cancer centers, Dr. Mailankody continues to shape the development and delivery of next-generation treatments for multiple myeloma and related plasma cell disorders.
Health insurance plans can change over time. If your plan isn't listed below, it may still be accepted by this doctor. Always contact the doctor's office to confirm your coverage.
